生脉辅助治疗病毒性心肌炎临床疗效分析  

Treatment with Integrative Medicine Clinical viral analyzed retrospectively

作　　者：张俊彪[1] 

机构地区：[1]新乡医学院第一附属医院心内科,卫辉453100

出　　处：《中国医疗前沿》2010年第16期35-35,48,共2页China Healthcare Innovation

摘　　要：目的探讨中西医结合治疗病毒性心肌炎的价值。方法将我院2009年6月～2010年6月确诊为病毒性心肌炎的患者60例随机分为治疗组和对照组各30例,对照组给予西药常规治疗,治疗组在常规治疗前提下加用生脉注射液,疗程均为15d。结果治疗组临床总有效率为93.3%,与对照组73.3%比较,差异有统计学意义,在心肌酶指标降低方面,治疗组与对照组相比,改善明显,且差异有统计学意义。结论病毒性心肌炎在西药常规治疗基础上加用生脉注射液,临床效果明显,证明中西医结合治疗病毒性心肌炎具有临床推广价值。Objective Treatment with Integrative Medicine Clinical viral analyzed retrospectively. Method Hospital in June 2009-2010, diagnosed as viral myocarditis60 patients were randomly divided into treatment group and control group, the control group, 30 patients received conventional western medicine treatment, the treatment group, 30 cases of conventional treatment associated with Shengmai injection, a course of 15 days. Results The clinical total effective rate was 93.3%, compared with the control group 73.3% statistically significant reduction in the target enzyme, the treatment group compared with the control group, improved significantly, and the difference was significant. Conclusion Viral myocarditis in Western medicine based on the use of conventional add to shengmai injection, the clinical effect is obvious,that Integrative Medicine has a clinical value of Promotion.

关 键 词：病毒性心肌炎 疗效 

分 类 号：R542.21[医药卫生—心血管疾病]